Zimmer Biomet Holdings Stock Forecast for 2023 - 2025 - 2030
Updated on 04/18/2024
Zimmer Biomet Holdings Stock Forecast and Price Target
According to esteemed experts, the average price target for Zimmer Biomet Holdings to reach this year is $136.00, with a potential upside of approximately 12.12%. This prediction is based on a high estimate of $175.00 and a low estimate of $109.00. Even if you're not interested in ZBH stock, you may be interested in its competitors.
12.12% Upside
Zimmer Biomet Holdings Fair Value Forecast for 2023 - 2025 - 2030
Zimmer Biomet Holdings's Price has decreased by 100.00% In the last four years, from $97.18 to $0.00. In the next year, analysts believe that Fair Value will reach $131.46 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$144.77 | Buy/Sell | $174.55 | 17.43% |
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$105.90 | Buy/Sell | $118.92 | 19.92% |
| ISRG Stock Forecast | Intuitive Surgical | Outperform |
13
|
$374.17 | Buy/Sell | $408.45 | 14.39% |
| SYK Stock Forecast | Stryker Corp | Outperform |
10
|
$336.03 | Buy/Sell | $353.16 | 9.07% |
| SAN Stock Forecast | Sanofi | Outperform |
16
|
86.18€ | Buy/Sell | 102.80€ | 25.32% |
Zimmer Biomet Holdings Revenue Forecast for 2023 - 2025 - 2030
Zimmer Biomet Holdings's Revenue has seen impressive growth In the last three years, rising from $7.02B to $7.39B – a growth of 5.26%. In the following year, the 14 analysts surveyed believe that Zimmer Biomet Holdings's Revenue will decrease by 0.94%, reaching $7.32B. For the next seven years, the forecast is for Revenue to grow by 14.96%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MDT Stock Forecast | Medtronic | Outperform |
11
|
$79.08 | Buy/Sell | $92.47 | 20.76% |
| ZTS Stock Forecast | Zoetis | Outperform |
18
|
$151.94 | Buy/Sell | $220.47 | 45.78% |
| EW Stock Forecast | Edwards Lifesciences Corp | Outperform |
11
|
$87.24 | Buy/Sell | $91.18 | 11.19% |
.jpg)
Zimmer Biomet Holdings Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Zimmer Biomet Holdings's Dividend per Share has decreased from $0.96 to $0.96 – a 0.00% drop! For the next year, analysts predict that Dividend per Share will reach $0.99 – an increase of 3.13%. Over the next seven years, experts believe that Zimmer Biomet Holdings's Dividend per Share will grow at a rate of 0.46%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MMM Stock Forecast | 3M | Hold |
10
|
$90.96 | Buy/Sell | $109.39 | 9.94% |
| SGO Stock Forecast | Compagnie de Saint-Gobain | Outperform |
10
|
71.08€ | Buy/Sell | 69.97€ | 12.55% |
| WST Stock Forecast | West Pharmaceutical Services | Outperform |
18
|
$377.36 | Buy/Sell | $380.80 | 0.70% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| RMD Stock Forecast | ResMed Inc | Outperform |
17
|
$173.83 | Buy/Sell | $201.32 | 17.93% |
| CAH Stock Forecast | Cardinal Health Inc | Hold |
13
|
$106.52 | Buy/Sell | $108.07 | 8.43% |
| STE Stock Forecast | STERIS | Outperform |
13
|
$200.24 | Buy/Sell | $238.33 | 21.36% |
Zimmer Biomet Holdings EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Zimmer Biomet Holdings's EBITDA has seen an increase, rising from $1.96B to $2.43B. This represents a growth of 23.82%. Analysts predict that Zimmer Biomet Holdings's EBITDA will increase in the upcoming year, reaching $2.52B. This would represent an increase of 3.75%. Over the next seven years, experts predict that Zimmer Biomet Holdings's EBITDA will grow at a rate of 38.75%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| COO Stock Forecast | The Cooper Companies | Outperform |
13
|
$89.86 | Buy/Sell | $391.40 | 22.41% |
| HOLX Stock Forecast | Hologic | Outperform |
8
|
$74.92 | Buy/Sell | $81.06 | 12.12% |
| VTRS Stock Forecast | Viatris Inc | Hold |
8
|
$11.10 | Buy/Sell | $11.73 | 8.11% |
Zimmer Biomet Holdings EBIT Forecast for 2023 - 2025 - 2030
Zimmer Biomet Holdings's EBIT has seen growth In the last three years, going from $930.90M to $1.48B – a gain of 58.95% In the next year, analysts believe that EBIT will reach $2.10B – an increase of 41.64%. For the next seven years, the forecast is forEBIT to grow by 75.35%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SN. Stock Forecast | Smith & Nephew | Outperform |
18
|
£9.60 | Buy/Sell | £16.09 | 70.94% |
| TFX Stock Forecast | Teleflex Inc | Hold |
13
|
$208.30 | Buy/Sell | $263.46 | 27.22% |
| HSIC Stock Forecast | Henry Schein | Hold |
7
|
$70.20 | Buy/Sell | $75.16 | 15.67% |
Zimmer Biomet Holdings EPS Price Prediction Forecast for 2023 - 2025 - 2030
Zimmer Biomet Holdings's EPS has decreased by 100.00% In the last four years, from $5.67 to $0.00. In the next year, analysts believe that EPS will reach $7.67 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GMED Stock Forecast | Globus Medical | Outperform |
16
|
$51.20 | Buy/Sell | $64.58 | 17.19% |
| XRAY Stock Forecast | DENTSPLY SIRONA | Outperform |
17
|
$30.36 | Buy/Sell | $36.00 | 22.86% |
| NVST Stock Forecast | Envista Holdings | Hold |
16
|
$19.59 | Buy/Sell | $29.00 | 17.41% |
Site Navigation
.jpg)